India to Belgium: Ondansetron Export Trade Route

The India to Belgium Ondansetron corridor is one of India's established pharmaceutical export routes, with 142 shipments documented worth a combined $2.8M USD. The route is dominated by BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, which alone accounts for roughly 83% of all export value, reflecting the consolidated nature of India's ondansetron manufacturing sector.

Across 10 active suppliers, the average shipment value stands at $19.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with ondansetron's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 19.7%, placing it at rank #12 among India's top ondansetron export destinations globally.

On the import side, key buyers of Indian ondansetron in Belgium include BAXTER DISTRIBUTION CENTRE EUROPE S, BAXTER DISTRIBUTION CENTRE EUROPE S , BAXTER DISTRIBUTION CENTRE EUROPE and 12 others. BAXTER DISTRIBUTION CENTRE EUROPE S is the single largest importer with 70 shipments valued at $2.3M USD.

India's ondansetron exports to Belgium are driven primarily by a handful of large-scale manufacturers. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED with 70 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Belgium benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED , CADILA PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $19.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ondansetron 2mg/ml solution for injectio and ondansetron 2 mg/ml solution for injecti , suggesting that buyers in Belgium tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, BAXTER DISTRIBUTION CENTRE EUROPE S is the largest importer with 70 shipments worth $2.3M USD — representing 83% of all ondansetron imports from India on this route. A total of 15 buyers are active on this corridor.